Management of the Kidney Transplant Recipient

Primary Care - Clinics in Office Practice

Volumn 35, Issue 3, 2008, Pages 433-450

  Padiyar, Aparna ^a,b   Akoum, Fadi H ^a,b   Hricik, Donald E ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; AZATHIOPRINE; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CLARITHROMYCIN; CORTICOSTEROID; CYCLOSPORIN; DILTIAZEM; ERYTHROMYCIN; EZETIMIBE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICARDIPINE; PHENYTOIN; RAPAMYCIN; RIFABUTIN; RITONAVIR; TACROLIMUS; VERAPAMIL; VORICONAZOLE;

BONE DISEASE; CARDIOVASCULAR DISEASE; CHRONIC ALLOGRAFT NEPHROPATHY; DIABETES MELLITUS; DRUG MECHANISM; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY ALLOGRAFT REJECTION; KIDNEY INFECTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RECIPIENT; REVIEW;

ANTIBODIES, MONOCLONAL; BONE DISEASES; CARDIOVASCULAR DISEASES; COMMUNICABLE DISEASES; DIABETES MELLITUS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES;

EID: 49349090771     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2008.03.003     Document Type: Review

References (41)

1. Wolfe R.A., Ashby V.B., Milford E.L., et al. Comparison of mortality in all patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341 (1999) 1725-1730
2. Foley R.N., Parfrey P.S., and Sarnak M.J. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9 Suppl 12 (1998) S16-S23
3. Toussaint C., Kinnaert P., and Vereerstraeten P. Late mortality and morbidity five to eighteen years after kidney transplantation. Transplantation 45 (1988) 554-558
4. Merion R.M., Ashby U.B., Wolfe R.A., et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 294 (2005) 2726-2733
5. O'Connor K.J., and Delmonico F.L. Increasing the supply of kidneys for transplantation. Semin Dial 18 (2005) 460-462
6. Djamali A., Samaniego M., Muth B., et al. Medical care of kidney transplant recipients after the first posttransplant year. Clin J Am Soc Nephrol 1 (2006) 623-640
7. Kasiske B.L., Guijarro C., Massy Z.A., et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7 (1996) 158-165
8. Lindholm A., Albrechtsen D., Frodin L., et al. Ischemic heart disease: major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 60 (1995) 451-457
9. Crutchlow M.F., and Bloom R.D. Transplant-associated hyperglycemia: a new look at an old problem. Clin J Am Soc Nephrol 2 2 (2007) 343-355
10. Burroughs T.E., Swindle J., Takemoto S., et al. Diabetic complications associated with new onset diabetes mellitus in renal transplant recipients. Transplantation 83 (2007) 1027-1034
11. Padiyar A., and Rahman M. Ambulatory blood pressure monitoring: an argument for wider clinical use. Cleve Clin J Med 74 11 (2007) 831-838
12. Blum C.B. Effects of sirolimus on lipids in renal allograft recipients: an analysis using the Framingham risk model. Am J Transplant 2 (2002) 551-559
13. Morales J.M. Cardiovascular risk profile in patients treated with sirolimus after renal transplantation. Kidney Int 92 Suppl (2006) S69-S73
14. Fellström B., Holdaas H., Jardine A.G., et al. Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial. Kidney Int 66 4 (2004) 1549-1555
15. Jardine A.G., Fellström B., Logan J.O., et al. Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study. Am J Kidney Dis 46 3 (2005) 529-536
16. Villeneuve P.J., Schaubel D.E., Fenton S.S., et al. Cancer incidence among Canadian kidney transplant recipients. Am J Transplant 7 4 (2007) 941-948
17. Vajdic C.M., McDonald S.P., McCredie M.R., et al. Cancer incidence before and after kidney transplantation. JAMA 296 23 (2006) 2823-2831
18. Kasiske B.L., Snyder J.J., Gilbertson D.T., et al. Cancer after kidney transplantation in the United States. Am J Transplant 4 6 (2004) 905-913
19. Kauffman H.M., Cherikh W.S., McBride M.A., et al. Post-transplant de novo malignancies in renal transplant recipients: the past and present. Transpl Int 8 (2006) 607-620
20. Grulich A.E., van Leeuwen M.T., Falster M.O., et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370 (2007) 59-67
21. Weisinger J.R., Carlini R.G., Rojas E., et al. Bone disease after renal transplantation. Clin J Am Soc Nephrol 1 (2006) 1300-1313
22. Hamdy N. Calcium and bone metabolism pre and post-kidney transplantation. Endocrinol Metab Clin North Am 36 (2007) 923-935
23. Wilkinson A. Protocol transplant biopsies: are they really needed?. Clin J Am Soc Nephrol 1 (2006) 130-137
24. Mulay A.V., Cockfield S., Stryker R., et al. Conversion from calcineurin inhibitors to sirolimus for chronic renal allograft dysfunction: a systematic review of the evidence. Transplantation 82 9 (2006) 1153-1162
25. Fishman J.A., and Rubin R.H. Infection in organ-transplant recipients. N Engl J Med 338 (1998) 1741-1751
26. Rubin R.H. Infection in the organ transplant recipient. In: Rubin R.H., and Young L.S. (Eds). Clinical approach to infection in the compromised host. 4th edition (2002), Plenum Medical Book Company, New York
27. Singh N. Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis; a call to heed the mounting evidence. Clin Infect Dis 40 (2005) 704-708
28. Hirsch H.H., Brennan D.C., Drachenberg C.B., et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 79 (2005) 1277-1286
29. American Society of Transplantation. Infectious Disease Community of Practice. Guidelines for the prevention and management of infectious complications of solid organ transplantation. Am J Transplant 4 Suppl 10 (2004) 1-166
30. Kotton C.N., Ryan E.T., and Fishman J.A. Prevention of infection in adult travelers after solid organ transplantation. Am J Transplant 5 (2005) 8-14
31. Kirk A. Induction immunosuppression. Transplantation 82 (2006) 593-602
32. Augustine J.J., and Hricik D.E. Steroid sparing in kidney transplantation: changing paradigms, improving outcomes, and remaining questions. Clin J Am Soc Nephrol 1 (2006) 1080-1089
33. Kahan B.D. The era of cyclosporine: twenty years forward, twenty years back. Transplant Proc 36 Suppl 2 (2004) 91S-378S
34. Fung J.J. Tacrolimus and transplantation: a decade in review. Transplantation 77 Suppl 9 (2004) S41-S43
35. Ciancio G.J., Miller J., and Gonwa T.A. Review of major clinical trials with mycophenolate mofetil in renal transplantation. Transplantation 80 Suppl 2 (2005) S191-S200
36. Abraham R.T. Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling. Curr Opin Immunol 10 3 (1998) 330-336
37. Augustine J.J., and Hricik D.E. Experience with everolimus. Transplant Proc 36 Suppl 2 (2004) 500S-503S
38. Meier-Kriesche H.U., Li S., Gruessner R.W., et al. Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant 6 Suppl 5 (2006) 111-131
39. Opelz G., Zeier M., Laux G., et al. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report. J Am Soc Nephrol 17 (2006) 3257-3262
40. Ozsoy R.C., van Leuven S.I., Kastelein J.J., et al. The dyslipidemia of chronic renal disease: effects of statin therapy. Curr Opin Lipidol 17 (2006) 659-666
41. Palmer S.C., Strippoli G.F., and McGregor D.O. Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials. Am J Kidney Dis 45 (2005) 638-649